160 related articles for article (PubMed ID: 26084673)
1. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.
Wang L; Man N; Sun XJ; Tan Y; García-Cao M; Liu F; Hatlen M; Xu H; Huang G; Mattlin M; Mehta A; Rampersaud E; Benezra R; Nimer SD
Blood; 2015 Jul; 126(5):640-50. PubMed ID: 26084673
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
[TBL] [Abstract][Full Text] [Related]
3. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro.
Li W; Wang H; Kuang CY; Zhu JK; Yu Y; Qin ZX; Liu J; Huang L
Mol Cell Biochem; 2012 Apr; 363(1-2):135-45. PubMed ID: 22139302
[TBL] [Abstract][Full Text] [Related]
4. Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.
Man N; Sun XJ; Tan Y; García-Cao M; Liu F; Cheng G; Hatlen M; Xu H; Shah R; Chastain N; Liu N; Huang G; Zhou Y; Sheng M; Song J; Yang FC; Benezra R; Nimer SD; Wang L
Blood; 2016 May; 127(19):2322-6. PubMed ID: 26944543
[TBL] [Abstract][Full Text] [Related]
5. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
Xu L; Zhang Y; Gao M; Wang G; Fu Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of differentiation proteins protect against oxidative stress by regulating the antioxidant-mitochondrial response in mouse beta cells.
Bensellam M; Montgomery MK; Luzuriaga J; Chan JY; Laybutt DR
Diabetologia; 2015 Apr; 58(4):758-70. PubMed ID: 25636209
[TBL] [Abstract][Full Text] [Related]
7. FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1.
Birkenkamp KU; Essafi A; van der Vos KE; da Costa M; Hui RC; Holstege F; Koenderman L; Lam EW; Coffer PJ
J Biol Chem; 2007 Jan; 282(4):2211-20. PubMed ID: 17132628
[TBL] [Abstract][Full Text] [Related]
8. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of hyperactivated AKT1 with additional genes activated in leukemia drives hematopoietic progenitor cells to cell cycle block and apoptosis.
Tang Y; Halvarsson C; Nordigården A; Kumar K; Åhsberg J; Rörby E; Wong WM; Jönsson JI
Exp Hematol; 2015 Jul; 43(7):554-64. PubMed ID: 25931014
[TBL] [Abstract][Full Text] [Related]
10.
Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J
Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526
[No Abstract] [Full Text] [Related]
11. Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.
Hao F; Pysz MA; Curry KJ; Haas KN; Seedhouse SJ; Black AR; Black JD
J Biol Chem; 2011 May; 286(20):18104-17. PubMed ID: 21454537
[TBL] [Abstract][Full Text] [Related]
12. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
13. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
14. Abnormal regulation of miR-29b-ID1 signaling is involved in the process of decitabine resistance in leukemia cells.
Ma J; Wen X; Xu Z; Xia P; Jin Y; Lin J; Qian J
Cell Cycle; 2023 May; 22(10):1215-1231. PubMed ID: 37032592
[TBL] [Abstract][Full Text] [Related]
15. Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway.
Cheng YJ; Tsai JW; Hsieh KC; Yang YC; Chen YJ; Huang MS; Yuan SS
Cancer Lett; 2011 Aug; 307(2):191-9. PubMed ID: 21536374
[TBL] [Abstract][Full Text] [Related]
16. ID1 Controls Aggressiveness of Salivary Gland Cancer Cells via Crosstalk of IGF and AKT Pathways.
Sumida T; Kamata YU; Kobayashi Y; Ishikawa A; Mori Y
Anticancer Res; 2016 Aug; 36(8):3865-70. PubMed ID: 27466488
[TBL] [Abstract][Full Text] [Related]
17. Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis.
Niu B; Liu J; Lv B; Lin J; Li X; Wu C; Jiang X; Zeng Z; Zhang XK; Zhou H
Nat Commun; 2021 May; 12(1):2809. PubMed ID: 33990575
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia.
Geest CR; Buitenhuis M; Vellenga E; Coffer PJ
Haematologica; 2009 Aug; 94(8):1075-84. PubMed ID: 19644139
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.
Mistry H; Hsieh G; Buhrlage SJ; Huang M; Park E; Cuny GD; Galinsky I; Stone RM; Gray NS; D'Andrea AD; Parmar K
Mol Cancer Ther; 2013 Dec; 12(12):2651-62. PubMed ID: 24130053
[TBL] [Abstract][Full Text] [Related]
20. Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response.
Long J; Fang WY; Chang L; Gao WH; Shen Y; Jia MY; Zhang YX; Wang Y; Dou HB; Zhang WJ; Zhu J; Liang AB; Li JM; Hu J
Leukemia; 2017 Dec; 31(12):2761-2770. PubMed ID: 28462918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
